- Tyna Moore, ND, DC
- Mimi Guarneri, MD
Evolution of Medicine is thrilled to announce a special Functional Forum on one of the hottest topics in medicine today: GLP-1 agonists. Due to the growing metabolic health crisis worldwide, practitioners and patients alike are interested in the weight loss and metabolic health benefits of GLP-1 agonists like semaglutide, commonly known by the brand names Wegovy, Ozempic or Rybelsus.
Now that millions of Americans have been prescribed a GLP-1 agonist, functional medicine practitioners may be wondering the following: Do these drugs synergize with functional medicine principles? Is this a healthy trend? How can these tools be used safely and effectively?
We have invited an internationally recognized expert to speak on this topic, Mimi Guarneri, MD, an author, renowned cardiologist, and the founder and president of The Academy of Integrative Health and Medicine. Dr. Guarneri will also discuss semaglutide and obesity management at the upcoming PLMI conference.
Joining her are a few special guests who are deeply involved in research on GLP-1 agonists, including their benefits and side effects, and they will discuss how functional medicine practitioners can work effectively to deal with the epidemic of chronic illness and metabolic disease.
One of these special guests joining Dr. Guarneri is Tyna Moore, ND, DC. Dr. Moore builds on decades of experience in musculoskeletal and metabolic health, and she has delved deeply into GLP-1 agonists. Bring your questions and join us live as Dr. Guarneri and Dr. Moore cover these critical topics. You can also send us your questions on X/Twitter with #FunctionalForum.